All Topics

Subscribe
Article
Swiss Court Rejects Similarity Between Medical Products And Medical Services In CannaMed Trademark Dispute
A pharmaceutical company's trademark dispute over 'CannaMed' raises critical questions about brand protection in the rapidly evolving cannabis and medical sectors. The case highlights the intersection of traditional pharmaceutical branding with emerging cannabis industry nomenclature. Legal and commercial implications of this trademark conflict could set important precedents for companies operating at the convergence of these two industries.
Netherlands IP
NG
Novagraaf Group
See more